US Drug Recall Register
Class III · Low risk Terminated Initiated Aug 11, 2017 (9 years ago)

Phentermine Capsules

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Failed Impurities/Degradation Specifications:Out of specification results for individual unknown impurities at 30th month Room Temperature Retained Sample stabilities test .

What was recalled

Phentermine Capsules, 15 mg, a) 7-count bottle (NDC 55289-791-07), b) 14-count bottle ( NDC 55289-791-14), c) 21-count bottle (NDC 55289-791-21), d) 30-count bottle (NDC 55289-791-30), e) 60-count bottle (NDC 55289-791-60), Packaged by PD-Rx Pharmaceuticals, Incorporated, Oklahoma City, OK. 73127 Mfg: KVK-Tech, Inc. Newtown, PA 18940

Recalling firm
PD-Rx Pharmaceuticals, Inc.
NDC code
55289-791-07
Origin
OK, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1118-2017

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Phentermine recalls

See all
Class II · Moderate risk Terminated

Phentermine HCL 37.5mg 100 C4

Reason CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Cardinal Health Inc. D-0502-2021
Class II · Moderate risk Terminated

Phentermine HCL 30mg 100 C4

Reason CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Cardinal Health Inc. D-0501-2021
Class II · Moderate risk Terminated

Phentermine

Reason cMGP Deviations: Drug products repackaged into pouches without supporting stability studies.

Calvin Scott & Company, Inc. NDC 00527-0597-10 D-0011-2021
Class II · Moderate risk Terminated

Phentermine HCL Blue Speckled tablets

Reason CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.

Calvin Scott & Company, Inc. NDC 10702-0025-10 D-1532-2020